Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits.

Alzheimer’s disease is a growing health concern around the world. It affects millions of people and is one of the leading ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. This week delivered a sobering reminder that Alzheimer’s disease ...

An experimental pill could slow memory loss and brain shrinkage in some Alzheimer’s patients, new research suggests. The pill, called ALZ-801 (valiltramiprosate), was shown to be effective in people ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers reported 3-year outcomes for both anti-amyloid drugs, lecanemab (Leqembi) and ...

Brand new research shows staying active may protect your brain from Alzheimer’s. This comes one day after we told you about breakthroughs happening in Georgia at Emory University. To protect your ...

Families across Georgia are finding new hope in the fight against Alzheimer’s disease, thanks to promising treatments being studied at Emory’s Goizueta Brain Health Institute. The treatment involves ...